Michael J. Doherty, Head of Product Development at Foundation Medicine, Inc. (FMI), sold 2 shares at $72.40 ($145) on 2018-04-03, disclosed to the SEC on 2018-04-05.
Open-market sale of $145 FMI by Head of Product Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |